Ironwood Pharmaceuticals Faces Delisting Notice
Ticker: IRWD · Form: 8-K · Filed: Jun 3, 2025 · CIK: 1446847
| Field | Detail |
|---|---|
| Company | Ironwood Pharmaceuticals Inc (IRWD) |
| Form Type | 8-K |
| Filed Date | Jun 3, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
TL;DR
Ironwood Pharma got a delisting warning. Big trouble ahead?
AI Summary
Ironwood Pharmaceuticals, Inc. filed an 8-K on May 28, 2025, to report a notice of delisting or failure to satisfy a continued listing rule. The company, incorporated in Delaware with its principal executive offices in Boston, MA, is subject to standard SEC reporting requirements.
Why It Matters
This filing indicates potential issues with Ironwood Pharmaceuticals' continued listing on a stock exchange, which could impact its stock price and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's stock trading and overall financial health.
Key Players & Entities
- Ironwood Pharmaceuticals, Inc. (company) — Registrant
- May 28, 2025 (date) — Date of Earliest Event Reported
- Delaware (jurisdiction) — State of Incorporation
- Boston, Massachusetts (location) — Address of Principal Executive Offices
- 001-34620 (identifier) — Commission File Number
FAQ
What specific listing rule or standard has Ironwood Pharmaceuticals failed to satisfy?
The filing does not specify the exact rule or standard that Ironwood Pharmaceuticals has failed to satisfy, only that a notice has been issued.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is May 28, 2025.
In which state is Ironwood Pharmaceuticals, Inc. incorporated?
Ironwood Pharmaceuticals, Inc. is incorporated in Delaware.
What is the address of Ironwood Pharmaceuticals' principal executive offices?
The address of Ironwood Pharmaceuticals' principal executive offices is 100 Summer Street, Suite 2300, Boston, Massachusetts 02110.
What is the Commission File Number for Ironwood Pharmaceuticals, Inc.?
The Commission File Number for Ironwood Pharmaceuticals, Inc. is 001-34620.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 3, 2025 regarding IRONWOOD PHARMACEUTICALS INC (IRWD).